https://www.pharmaceutical-technology.com/data-insights/cetuximab-biobetter-shanghai-henlius-biotech-nasopharyngeal-cancer-likelihood-of-approval/
Cetuximab biobetter is under clinical development by Shanghai Henlius Biotech and currently in Phase II for Nasopharyngeal Cancer.
nasopharyngeal cancercetuximabbiobettershanghaibiotech
https://www.pharmaceutical-technology.com/data-insights/cetuximab-biobetter-shanghai-henlius-biotech-squamous-non-small-cell-lung-cancer-likelihood-of-approval/
Cetuximab biobetter is under clinical development by Shanghai Henlius Biotech and currently in Phase II for Squamous Non-Small Cell Lung Cancer.
cetuximabbiobettershanghaibiotechsquamous
https://www.fooddive.com/news/biobetter-opens-molecular-farming-plant-using-tobacco-cultivated-meat/693441/?utm_source=news.climatehack.global&utm_medium=referral&utm_campaign=climatehack-vol-64-vc-meets-biodiversity
The Israeli startup created a manufacturing platform for producing growth factors using tobacco plants as self-sustained, animal-free bioreactors.
molecular farmingbiobetteropensplantusing